NIH Common Fund Researchers Uncover Structure of Important Target for Drug DesignResearchers have uncovered a potent class of small molecules that selectively turn on the S1P1 receptor.
"Popeye" Proteins Help the Heart Adapt to StressStudy help scientists to develop new treatments for abnormal heart rhythms.
Rapid Bone Loss Possible Side Effect of Anti-Obesity DrugResearch from UT Southwestern Medical Center has raised concern about the safe use of fibroblast growth factor 21.
NIH Study Uncovers Probable Mechanism Underlying Resveratrol ActivityFindings may settle scientific debate surrounding this chemical found in red wine and other foods.
Proteomic Analysis of Zebrafish Caudal Fin RegenerationResearchers have analyzed the biomechanism of zebrafish caudal fin regeneration at various time points based on differential proteomics approaches.
OGT Releases New Whitepaper for Aiding Biomarker DiscoveryThe new document explores the need for biomarkers as indicators of disease, and discusses the vast potential of autoantibodies as markers of early disease development.
Proteomics Analyses of the Opportunistic Pathogen Burkholderia vietnamiensis using Protein Fractionations and Mass SpectrometryResearchers from the University of Arizona have identified more than 1200 proteins, approximately 16% of the proteins coded from the annotated genome of Burkholderia species.
Important Gene-Regulation Proteins Pinpointed by New MethodA novel technique has been developed and demonstrated at Penn State to map the proteins that read and regulate chromosomes.
Miraculins Files with Health Canada for PreVu Medical Device LicenseThe medical diagnostic company announced that it has filed a class II medical device license application with Health Canada for the PreVu Non-Invasive Skin Cholesterol Point of Care (POC) Test.
NIH Study Shows 32 Million Americans Have AutoAntibodies that Target their Own TissuesResearchers in Gainesville at the University of Florida also participated in the study.
